PsychPartnersPsychPartners
 
PsychPartnersPsychPartners
New Patients
  • Providers & Locations
    • Providers
    • Locations
  • Self Help
    • Self Help Blog
    • Research for the Public
    • Lifestyle
    • Supplements
    • Psych Meds
    • Pocket Psychiatrist Podcast
    • Depression & Bipolar Workbook
  • Psych Education
    • Research Updates
      • Daily Psych Blog
      • Top Research
      • LinkedIn
      • Facebook
      • X
      • Bluesky
    • Books
    • Carlat Psych Podcast
    • Talks
  • Join our Team
    • Primary Care Partners
    • Therapy Partners
    • Employment
  • Contact
Buprenorphine and Naltrexone for Impaired Physicians
AlcoholOpioidsResearchSubstance Use

Buprenorphine and Naltrexone for Impaired Physicians

June 17, 2026by Chris Aiken, MD0
Can GLP-1s Both Cause and Prevent Pancreatitis?
AlcoholGLP1 AgonistsMed-PsychResearchResearch for the PublicSide EffectsTop Research

Can GLP-1s Both Cause and Prevent Pancreatitis?

June 15, 2026by Chris Aiken, MD1
Pioglitazone in Alcohol Use Disorder: An Inflammatory Signal
Addiction MedsAlcoholDisordersMedicationsResearchSubstance Use

Pioglitazone in Alcohol Use Disorder: An Inflammatory Signal

June 13, 2026by Chris Aiken, MD0
Topiramate and Naltrexone Reduce Alcohol Through Common Mechanism
AlcoholMedicationsResearchSubstance Use

Topiramate and Naltrexone Reduce Alcohol Through Common Mechanism

June 9, 2026by Chris Aiken, MD0
FDA Moves the Goalposts on Alcohol Treatment
Addiction MedsAlcoholResearchSubstance Use

FDA Moves the Goalposts on Alcohol Treatment

June 2, 2026by Chris Aiken, MD0
Mental Health Rises and Falls for New Dads
AlcoholAnxietyDepressionResearchResearch for the PublicSubstance Use

Mental Health Rises and Falls for New Dads

May 12, 2026by Chris Aiken, MD1
Carbonated Water Cuts Alcohol and Snacking
AlcoholLifestyleNutritionResearchResearch for the Public

Carbonated Water Cuts Alcohol and Snacking

May 11, 2026by Chris Aiken, MD0
A GLP-1 Trial Changes the Score in Alcohol
AlcoholGLP1 AgonistsMedicationsResearchResearch for the PublicSubstance UseTop Research

A GLP-1 Trial Changes the Score in Alcohol

May 5, 2026by Chris Aiken, MD0
Naltrexone-Baclofen Combo for Alcohol Craving
Addiction MedsAlcoholMedicationsResearchSubstance UseTop Research

Naltrexone-Baclofen Combo for Alcohol Craving

April 28, 2026by Chris Aiken, MD1
Personality Traits and Problem Drinking
AlcoholResearchSubstance Use

Personality Traits and Problem Drinking

April 7, 2026by Chris Aiken, MD0
Rethinking Sobriety Before Liver Transplant
AlcoholMed-PsychResearchSubstance Use

Rethinking Sobriety Before Liver Transplant

April 6, 2026by Chris Aiken, MD0
Zero-Alcohol Can Reverse Cirrhosis
AlcoholMed-PsychResearchResearch for the PublicSubstance Use

Zero-Alcohol Can Reverse Cirrhosis

April 6, 2026by Chris Aiken, MD0
A Therapy for Sleep in Alcohol Use Disorder
AlcoholResearchResearch for the PublicSleepSubstance UseTherapy

A Therapy for Sleep in Alcohol Use Disorder

March 28, 2026by Chris Aiken, MD0
Probiotics Fail in Substance-Induced Depression
AlcoholCannabisCocaineMethamphetamineOpioidsResearchSubstance UseSupplements

Probiotics Fail in Substance-Induced Depression

March 18, 2026by Chris Aiken, MD0
Ozempic for Alcohol Use Disorder
AlcoholMedicationsSubstance UseTop Research

Ozempic for Alcohol Use Disorder

April 1, 2025by Chris Aiken, MD0
A New Combination Pill for Alcohol Use Disorder
Addiction MedsAlcoholMedicationsResearchSubstance UseTop Research

A New Combination Pill for Alcohol Use Disorder

July 10, 2024by Chris Aiken, MD0
A GLP-1 Agonist Fails in Alcohol Use Disorder
AlcoholGLP1 AgonistsResearch

A GLP-1 Agonist Fails in Alcohol Use Disorder

October 11, 2022by Chris Aiken, MD0
Top Studies
All Studies
Self Help

Recent Posts

  • June 28, 2026Low Dose Antipsychotics, Real Risks

  • June 28, 2026Why We Prescribe When We Don't Know What's Wrong

  • June 28, 2026The Medical and Psychiatric Benefits of NAC

  • June 28, 2026AI Therapy for Anxiety: CBT vs Psychodynamic Chatbots

  • June 27, 2026A Laxative That Sharpens Memory

Categories

  • Addiction Meds
  • ADHD
  • Alcohol
  • Antidepressants
  • Antipsychotics
  • Anxiety
  • Autism
  • Benzodiazepines
  • Bipolar
  • Bipolar Meds
  • Cannabis
  • Child Psychiatry
  • Clozapine
  • Cocaine
  • Cognition
  • Dementia
  • Deprescribing
  • Depression
  • Devices
  • Difficult to Treat Depression
  • Disorders
  • Eating Disorders
  • ECT
  • Exercise
  • Geriatric Psychiatry
  • GLP1 Agonists
  • Hypnotics
  • Inflammation
  • Ketamine
  • Lifestyle
  • Light Therapy
  • Lithium
  • Med-Psych
  • Medications
  • Methamphetamine
  • Neuromodulation/TMS
  • Nutrition
  • OCD
  • Opioids
  • Personality Disorders
  • Psychedelics
  • PTSD
  • Research
  • Research for the Public
  • Schizophrenia and Psychosis
  • Sedatives
  • Sexual dysfunction
  • Side Effects
  • Sleep
  • Stimulants
  • Substance Use
  • Supplements
  • Therapy
  • Top Research
  • Women's Health
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_02.png?fit=161%2C245&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_03.png?fit=84%2C96&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/floating_image_10.png?fit=75%2C84&ssl=1
https://i0.wp.com/psych-partners.com/wp-content/uploads/2025/07/SquareLogoMediumThumn-min.jpg?resize=160%2C160&ssl=1

Collaborative mental health

©2025 Psych Partners USA | Terms of use | Cookie policy

Career opportunities
Chris Aiken, MD
LINKS
  • About us
    • Chris Aiken, MD
    • Team
    • Contact
    • Locations
ADMINISTRATIVE TEAM

Nancy Brandon,
Director of Operations

2016 Ashburn Lane
Clemmons, NC 27012

(336) 948-1876

nancy.brandon@psych-partners.com

ADMIN HOURS

Mon – Fri: 9am-5pm EST
Sat – Sun: Closed

bt_bb_section_top_section_coverage_image